Navigation Links
Doctors Urged to Look for Link Between Type 2 Diabetes, Sleep Apnea
Date:6/7/2008

Group pushes new clinical practices to have patients presenting with one checked for other

SATURDAY, June 7 (HealthDay News) -- The ties being found between type 2 diabetes and obstructive sleep apnea (OSA) indicate these disorders have major implications on public health, the International Diabetes Federation warns.

Up to 40 percent of people with OSA, a common breathing disorder, also have diabetes, recent studies suggest. Likewise, more than half of the people with type 2 diabetes suffer from some form of sleep disorder. Another recent study suggests treating OSA with continuous positive airway pressure (CPAP) improves insulin sensitivity in non-obese people.

The diabetes federation, in a statement expected to be made Saturday during a presentation at the American Diabetes Association's annual meeting in San Francisco, strongly recommends health-care professionals working with both conditions receive more education about the links between them. The federation also encouraged clinical practices be adopted so a person presenting with one condition is checked for the other.

The statement, which is also published in an article in Diabetes Research and Clinical Practice, calls for people with OSA to be routinely screened for metabolic disease and type 2 diabetes. It also says people with diabetes should be screened for OSA, especially when they have had classic symptoms such as heavy snoring or daytime sleepiness and poor workplace performance.

"Health policy makers and the general public must be made aware of the link between type 2 diabetes and sleep apnea, so that we can begin to address the significant economic burden and debilitating health consequences to both individuals and the community," Paul Zimmet, co-chair of the federation's Task Force on Epidemiology and Prevention, said in a prepared statement. "Today's statement is an urgent call to action to the medical community. It is imperative that we better understand the relationship between diabetes and sleep apnea through research and establish appropriate standards of care for managing diabetes and co-morbidities such as sleep apnea."

Annual costs of diabetes amount to $170 billion in the United States alone. While figures aren't available for OSA, it creates large indirect costs, because it contributes to lost workplace productivity, and work and transportation accidents. OSA also has ties to cardiovascular disease, stroke, and depression that have yet to be quantified.

More information

The National Institute of Neurological Disorders and Stroke has more about sleep apnea.



-- Kevin McKeever



SOURCE: Edelman Public Relations, news release, June 7, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Three Miami Area Doctors and Six Others Charged in $56 Million Health Care Fraud Schemes
2. U.S. Surgeon General Calls on Doctors to Prescribe Exercise
3. Doctors of Optometry, Parents, Educators and Legislators Applaud New Illinois Law Requiring Comprehensive Eye Exams for Children Starting School
4. Study: Doctors not always sure when to treat BP in people with diabetes
5. Study: Doctors Not Always Sure When to Treat Blood Pressure in People With Diabetes
6. Study: Doctors Significantly Less Likely to Provide Women with Treatments to Prevent Heart Attacks
7. Study Finds More Than One in Two Women are Too Embarrassed to Discuss Vaginal Discomfort With Their Doctors
8. Doctors Can Help Lower Hospital Costs
9. High Blood Pressure Still Slipping Past Doctors
10. Traditional Medicare Benefit Information Soon to be Available Online to Doctors and Hospitals through Blue Cross Blue Shield of Michigan Web Portal
11. Fertility Doctors: Studies Suggest Artificial Insemination Increasingly Second Choice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/21/2017)... Falls Church, VA (PRWEB) , ... September 21, ... ... Use Policy , **An FDAnews Management Report**, http://www.fdanews.com/products/54818-promotional-communication      , In the ... every edge they can get while staying in compliance with FDA rules. , ...
(Date:9/21/2017)... WA (PRWEB) , ... September 21, 2017 , ... ... technology using Microscan’s LVS 7510 at the Global GS1 Healthcare Conference 2017 in ... of the life-sciences industry for ensuring label quality and improving patient safety. ...
(Date:9/21/2017)... ... September 21, 2017 , ... FlipBelt, the fitness brand that ... detail to the athletic wear market with the launch of their FlipBelt Crops. , ... their essentials securely at their fingertips while at the gym, on the trail, or ...
(Date:9/20/2017)... ... September 20, 2017 , ... FirstAlign ( http://www.firstalign.com ), combines ... Artificial Intelligence (AI) thinking, announced today the launch of its revamped web presence. ... information that offers a more comprehensive understanding of the organization’s business and machine ...
(Date:9/20/2017)... ... September 20, 2017 , ... ... and commercialization, has just released a new white paper discussing the benefits ... than ever about medical device, pharmaceutical, and combination product organizations making sure ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)...   BioLife Solutions , Inc. (NASDAQ: BLFS ... grade cell and tissue hypothermic storage and ... , President and CEO, will be presenting at two investment ... Renshaw 19 th Annual Global Investment Conference on Tuesday, ... time). The conference is being held at the New York ...
(Date:9/6/2017)... , Sept. 6, 2017   PDI , a ... it will host an educational session focused on the ... infection (CLABSI) prevention at the 2017 Annual Scientific Meeting ... will take place at the Phoenix ... from Sept. 16-19, will also feature PDI,s ...
(Date:9/5/2017)... -- Sapheneia and Scannerside received FDA 510(k) clearance to ... third-party Vendor neutral CT product that makes it affordable ... current MITA standards. ... specifically designed to provide CT operators, prior to a ... a predefined threshold. Scannerside Dose Check is intended to ...
Breaking Medicine Technology: